Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico

NCT06907056 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

138

Enrollment

OTHER_GOV

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: dual therapy
DRUG: Standard Medical Therapy

Sponsor

José Antonio Mata Marín